Preoperative autologous blood donation for cardiac surgery in children

Narutoshi Hibino1, Mitsugi Nagashima, Harumitsu Sato

  • 1Department of Cardiovascular Surgery, Ehime Prefectural Central Hospital, 83 Kasuga, Matsuyama, Ehime, Japan. nhhibino@gmail.com

Insights

Preoperative autologous blood donation significantly reduced homologous blood transfusions in pediatric cardiac surgery patients. This safe and effective method benefits even young children under 15 kg.

Area of Science:

  • Pediatric Cardiac Surgery
  • Transfusion Medicine
  • Autologous Blood Donation

Background:

  • Homologous blood transfusion is common in pediatric cardiac surgery.
  • Limited data exists on autologous blood donation in young children.
  • Preoperative autologous blood donation (PABD) may reduce allogeneic blood use.

Purpose of the Study:

  • To evaluate the safety and efficacy of PABD in children undergoing cardiac surgery.
  • To assess the impact of PABD on homologous blood transfusion rates in pediatric patients.

Main Methods:

  • A prospective study of 50 children (6 months to 5 years) undergoing primary cardiac surgery.
  • 23 children donated autologous blood (10 mL/kg twice) preoperatively.
  • 27 age and weight-matched controls received standard care.

Main Results:

  • No complications were observed during autologous blood collection.
  • Homologous blood use was significantly lower in the autologous group (4.3%) vs. control (44.4%).
  • Hemoglobin levels remained comparable across both groups throughout the study period.

Conclusions:

  • PABD is safe and effective in reducing homologous blood transfusions in pediatric cardiac surgery.
  • The benefits of PABD extend to children weighing less than 15 kg.
  • PABD is a viable strategy for optimizing blood management in pediatric cardiac procedures.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...